267 related articles for article (PubMed ID: 19470394)
1. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.
Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q
J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394
[TBL] [Abstract][Full Text] [Related]
2. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
[TBL] [Abstract][Full Text] [Related]
3. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
[TBL] [Abstract][Full Text] [Related]
4. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
[TBL] [Abstract][Full Text] [Related]
5. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
6. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
[TBL] [Abstract][Full Text] [Related]
7. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
Yang Y; Wang J; Zhang X; Lu W; Zhang Q
J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q
Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332
[TBL] [Abstract][Full Text] [Related]
10. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
[TBL] [Abstract][Full Text] [Related]
11. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
12. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
Yang Y; Xie X; Yang Y; Zhang H; Mei X
J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel.
Zhao BX; Zhao Y; Huang Y; Luo LM; Song P; Wang X; Chen S; Yu KF; Zhang X; Zhang Q
Biomaterials; 2012 Mar; 33(8):2508-20. PubMed ID: 22197569
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
15. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
[TBL] [Abstract][Full Text] [Related]
16. Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells.
Zhang Y; Wang X; Wang J; Zhang X; Zhang Q
Pharm Res; 2011 May; 28(5):1167-78. PubMed ID: 21340573
[TBL] [Abstract][Full Text] [Related]
17. An EGFR/CD13 bispecific fusion protein and its enediyne-energized analog show potent antitumor activity.
Sheng W; Shang Y; Li L; Zhen Y
Anticancer Drugs; 2014 Jan; 25(1):82-91. PubMed ID: 24100279
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
19. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake.
Takara K; Hatakeyama H; Ohga N; Hida K; Harashima H
Int J Pharm; 2010 Aug; 396(1-2):143-8. PubMed ID: 20457236
[TBL] [Abstract][Full Text] [Related]
20. A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study.
Li Y; Yang F; Chen W; Liu J; Huang W; Jin M; Gao Z
Chem Pharm Bull (Tokyo); 2012; 60(9):1146-54. PubMed ID: 22976323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
